Aaron R Thorner

9PUBLICATIONS
67CO-AUTHORS
Predictive and prognostic markersLiquid biopsiesMolecular targetsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 21, 2026
Epigenetic dysregulation of metabolic programs mediates liposarcoma cell plasticity.

Erica M Pimenta, Amanda E Garza, Sabrina Y Camp

|Nov 28, 2024
Single-cell epigenetic profiling reveals an interferon response-high program associated with BAP1 deficiency in kidney cancer.

Sabrina Y Camp, Meng Xiao He, Michael S Cuoco

|Feb 01, 2023
Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.

Samuel Abbou, Kelly Klega, Junko Tsuji

|May 17, 2022
Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533.

Laura M Madanat-Harjuoja, Lindsay A Renfro, Kelly Klega

|May 13, 2022
Circulating Tumor DNA Is Associated with Response and Survival in Patients with Advanced Leiomyosarcoma.

Laura M Madanat-Harjuoja, Kelly Klega, Yao Lu

Pageof 2